Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Bearish
2
Neutral
7
Bullish
5
Bearish
26
Neutral
7
Bullish
13
Bearish
24
Neutral
0
Bullish
8
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Market Cap
₹ 94 Cr
P/E
9.45
Pharmaceuticals
Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
94 Cr
Low Risk
9.5
30.8
0.0
2.2
103.20
66.72
Sales CAGR
1Y
171.59%
3Y
—
5Y
—
10Y
—
Profit CAGR
1Y
1044.87%
3Y
—
5Y
—
10Y
117.60%
ROE
TTM
22.69%
3Y
15.08%
5Y
12.98%
10Y
9.51%
ROCE
TTM
25.33%
3Y
21.13%
5Y
18.23%
10Y
13.46%
Performance
MARKET LEADER
Valuation
REASONABLE
Growth
STABLE
Profitability
HIGH MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Turned 1 L into 9.17 L in last 5 Years